Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 03-2002 | |
| Sales | 0 | 0 | 0 | 0 | 39,601 |
| Cost of Goods | N/A | N/A | N/A | N/A | 36,956 |
| Gross Profit | N/A | N/A | N/A | N/A | 2,645 |
| Operating Expenses | 6,284 | 6,956 | 7,249 | 0 | 4,537 |
| Operating Income | -6,284 | -6,956 | -7,249 | N/A | -936 |
| Interest Expense | 0 | 0 | 0 | 0 | 737 |
| Other Income | 43 | 59 | 56 | 0 | 0 |
| Pre-tax Income | -6,241 | -6,897 | -7,193 | 0 | -1,673 |
| Income Tax | N/A | N/A | N/A | N/A | 14,536 |
| Net Income Continuous | -6,241 | -6,897 | -7,193 | N/A | -16,209 |
| Net Income | $-6,241 | $-6,897 | $-7,193 | $N/A | $-16,209 |
| EPS Basic Total Ops | -5.75 | -5.88 | -6.05 | N/A | -2.52 |
| EPS Basic Continuous Ops | -4.20 | -4.83 | -5.14 | N/A | -2.53 |
| EPS Diluted Total Ops | -5.75 | -5.88 | -6.05 | N/A | -2.52 |
| EPS Diluted Continuous Ops | -4.20 | -4.83 | -5.14 | N/A | -2.53 |
| EBITDA(a) | $-6,284 | $-6,956 | $-7,249 | $N/A | $260 |